Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gala Beykin

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Ophthalmology Science|May 8, 2026
ReplyMariella Saludares, Zachary Wennberg-Smith, Gala Beykin, et al.
Ophthalmology Science|January 26, 2026
A Phase I Randomized Trial of Topical Insulin for Glaucoma: Safety and Efficacy OutcomesMariella Saludares, Zachary Wennberg-Smith, Gala Beykin, et al.
Investigative Ophthalmology & Visual Science|August 18, 2021
Analysis of the Aqueous Humor Proteome in Patients With Age-Related Macular DegenerationBatya Rinsky, Gala Beykin, Michelle Grunin, et al.
Journal of Glaucoma|June 13, 2022
Structural and Metabolic Imaging After Short-term Use of the Balance Goggles System in Glaucoma Patients: A Pilot StudyMichelle T Sun, Gala Beykin, Wen-Shin Lee, et al.
Investigative Ophthalmology & Visual Science|February 28, 2020
Association of a Variant in VWA3A with Response to Anti-Vascular Endothelial Growth Factor Treatment in Neovascular AMDMichelle Grunin, Gala Beykin, Elior Rahmani, et al.
Medrxiv : the Preprint Server for Health Sciences|September 21, 2023
Genome-wide association study and genomic risk prediction of age-related macular degeneration in IsraelMichelle Grunin, Daria Triffon, Gala Beykin, et al.
Scientific Reports|June 6, 2024
Genome wide association study and genomic risk prediction of age related macular degeneration in IsraelMichelle Grunin, Daria Triffon, Gala Beykin, et al.
American Journal of Ophthalmology|November 15, 2021
Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure OutcomesGala Beykin, Laurel Stell, Muhammad Sohail Halim, et al.
American Journal of Ophthalmology|August 17, 2022
Corrigendum to Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes. Am J Ophthalmol 2022;234:223-234Gala Beykin, Laurel Stell, Muhammad Sohail Halim, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Ophthalmology Science|May 8, 2026
ReplyMariella Saludares, Zachary Wennberg-Smith, Gala Beykin, et al.
Ophthalmology Science|January 26, 2026
A Phase I Randomized Trial of Topical Insulin for Glaucoma: Safety and Efficacy OutcomesMariella Saludares, Zachary Wennberg-Smith, Gala Beykin, et al.
Investigative Ophthalmology & Visual Science|August 18, 2021
Analysis of the Aqueous Humor Proteome in Patients With Age-Related Macular DegenerationBatya Rinsky, Gala Beykin, Michelle Grunin, et al.
Journal of Glaucoma|June 13, 2022
Structural and Metabolic Imaging After Short-term Use of the Balance Goggles System in Glaucoma Patients: A Pilot StudyMichelle T Sun, Gala Beykin, Wen-Shin Lee, et al.
Investigative Ophthalmology & Visual Science|February 28, 2020
Association of a Variant in VWA3A with Response to Anti-Vascular Endothelial Growth Factor Treatment in Neovascular AMDMichelle Grunin, Gala Beykin, Elior Rahmani, et al.
Medrxiv : the Preprint Server for Health Sciences|September 21, 2023
Genome-wide association study and genomic risk prediction of age-related macular degeneration in IsraelMichelle Grunin, Daria Triffon, Gala Beykin, et al.
Scientific Reports|June 6, 2024
Genome wide association study and genomic risk prediction of age related macular degeneration in IsraelMichelle Grunin, Daria Triffon, Gala Beykin, et al.
American Journal of Ophthalmology|November 15, 2021
Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure OutcomesGala Beykin, Laurel Stell, Muhammad Sohail Halim, et al.
American Journal of Ophthalmology|August 17, 2022
Corrigendum to Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes. Am J Ophthalmol 2022;234:223-234Gala Beykin, Laurel Stell, Muhammad Sohail Halim, et al.
Pageof 2